AKAysegul Sevim Kecici

Aysegul Sevim Kecici

*This is an algorithmically generated author record based on publicly available information.

Aysegul Sevim Kecici has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up

    by Zekayi Kutlubay, Ayşegül SEVİM KEÇİCİ, Uğur Çeli̇k, Cem Mat

    Autoimmune bullous diseases, if left untreated, are life-threatening conditions affecting primarily skin and mucous membranes. These blistering disorders are characterized by epidermal or subepidermal detachment. Autoimmunity has the key role in pathogenesis, therefore immunosuppressive agents are the treatment of choice. The aim of this study is to document relative frequencies of different autoimmune bullous diseases, patient characteristics, treatment options and side effects in patients presenting to our bullous skin disease center, at Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Medical files were examined retrospectively for all patients with autoimmune bullous diseases who were followed-up between 2003 and 2019 at Bullous Skin Disease Center, at Istanbul University-Cerrahpaşa. A total of 346 patient files were examined. Pemphigus vulgaris was the most frequent autoimmune bullous disease, followed by bullous pemphigoid and pemphigus foliaceus according to our study. There is a general female predominancy for all autoimmune bullous diseases. Most commonly preferred treatment options were high dose daily corticosteroids. This retrospective study summarizes the patient characteristics, comorbidities, treatment choices and side effects in our 16 years of clinical practice.


  • Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: an open‐label study

    by A. S. Kecici, E. Polat, Z. Kutlubay

    Background Cutaneous ulcers of Behçet disease (BD) are rare but have high morbidity and resistance to conventional therapies. An important and essential aspect of ulcer management is debridement. Regarding maggot therapy (MT), excretions of green bottle fly, Lucilia sericata, are able to remove necrotic debris and promote healing. Aim With this study, we aimed to evaluate the efficacy of MT for cutaneous ulcers of BD. Methods In this open‐label trial, BD patients with refractory leg ulcers suitable for MT were enrolled. Maggot application was performed until complete debridement was achieved and all patients were followed‐up for 12 months afterwards, to assess the total healing of ulcers. Results Twenty‐four patients with 32 wounds were enrolled and 91,6% of all ulcers were completely debrided. Average time to debridement was 14.9 days and average number of cycles required was 5.3. Average ulcer size was decreased by 23% with treatment. Time to debridement was positively correlated with pre‐treatment ulcer size and duration of ulcer (p=0.00 and p=0.004) but wound depth, comorbidities, smoking, age or gender were not correlated with debridement time (p>0.05). During follow‐up, 79.1% of all ulcers healed completely. Duration of the wound, pre‐ and post‐treatment ulcer area and wound depth were positively correlated with average time required for total healing (p=0.027, p=0.00, p=0.041). Average time to total debridement was positively correlated with total healing time (p=0.007). Conclusions The findings presented in this first and unique study may provide key answers about factors affecting success rate of MT in BD cutaneous ulcers.


  • Open Access

    Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata

    by Zekayi Kutlubay, Ayşegül SEVİM KEÇİCİ, Övgü Aydin, Suphi Vehi̇d, Server Serdaroğlu

    Background and Objectives Alopecia areata is an inflammatory disease with a genetic and autoimmune basis. We aimed to study the efficacy, and safety of an immunomodulatory therapeutic agent, diphenylcyclopropenone, while manifesting the association with histopathological features, prognostic factors and side effects. Materials and Methods In this retrospective study, 98 patients (60 men, 38 women) with alopecia who were referred to the ?Hair Disease Polyclinic? at Department of Dermatology between 2011 and 2015 were included. Together with medical histories and dermatological examinations, all patients were taken a skin biopsy for histopathological examination prior to the therapy. Therapeutic success was evaluated on the basis of hair re-growth percentage. Results Regarding the overall treatment success, 33 (34%) patients had complete response, 16 (16%) patients had partial response (between 50-99%), 27 (28%) patients had minimal response (between 1-49%), and 22 (22%) patients were non-responders. Both genders were equally represented in the outcome. Conclusions There was a significant relation between the severity of alopecia and treatment outcome. (p=0.038) Patients with alopecia areata had significantly better response when compared to alopecia totalis and universalis. There was no statistically significant relation with other parameters such as disease duration, age, gender, atopy history, age of onset, and histopathological features.


  • Long‐term follow‐up effect of omalizumab in chronic spontaneous urticaria and its association with serum C‐reactive protein levels

    by Sevim Baysak, Aysegul Sevim Kecici, Bilal Dogan

    This study aims to determine the efficacy of omalizumab, a humanized monoclonal anti‐immunoglobulin E antibody, in patients with chronic spontaneous urticaria (CSU) refractory to conventional therapy, together with the evaluation of serum CRP levels. All the patients with a diagnosis of CSU who were continuously treated with omalizumab (300 mg/month) for at least 3 months between June 2016 and July 2019 were included in this study. Urticaria activity score (UAS‐7) was used for assessment of disease activity. Serum CRP levels were also retrospectively analyzed. When UAS‐7 scores before the initiation of therapy were compared to the week 4, 12, 24 and 36 scores after the treatment, each were significantly different from the pretreatment results. (p< .01) CRP level prior to treatment was found to be strongly correlated with baseline UAS scores of the patients’ (p:0,00). At the 12th week of treatment, decline of CRP level was positively and strongly correlated with the decline of UAS (p:0.037). In this study, mean UAS decreased, mean rescue medication use declined, and overall therapeutic response improved with omalizumab treatment. Additionally, significant correlation between the decline of CRP levels and treatment response was found.


  • Pathergy testing: prospective comparison of dermatoscopic evaluation and naked eye examination

    by Aysegul Sevim Kecici, Zekayi Kutlubay, Server Serdaroglu, Yalcin Tuzun

    Pathergy phenomenon is a non-specific tissue hyperreactivity reaction due to trauma and is a minor diagnostic criterion of Behcet's disease. In this study, 100 patients with a suspicion of Behcet's disease who were referred to Cerrahpasa Medical Faculty Dermatology department between 01.11.2014 and 31.01.2015 are included. Skin pathergy tests were applied to all the patients and results were evaluated by two dermatologists separately at 48th hour, each with naked eye and with dermatoscopy. Test results were scored on a scale of 0–6. At the end of the study, score results of naked eye and dermatoscopy for doctor number 1 were statistically similar. Same results applied for doctor number 2. However, naked eye results of doctor number 1 and 2 for the same patients were significantly different from each other (p 0.0372) and with dermatoscopy examination this difference was eliminated (p > 0.05). This study revealed that naked eye evaluation of pathergy test results can yield different results among different interpreters. Use of dermatoscopy during the evaluation process decreases interobserver variation and subjectivity of the test.


  • A Proposal for a New Severity Index for the Evaluation of Chronic Paronychia

    by Güldehan Atış, Fatih Göktay, Zeynep Altan Ferhatoğlu, Emre Kaynak, Ayşegül Sevim Keçici, Şirin Yaşar, Sema Aytekin

    Introduction: Chronic paronychia (CP) is an inflammatory disease of the nail folds. Staging of CP is important for clinicians. We developed an objective scale that evaluates each finding of CP separately in addition to evaluating the treatment process and follow-up. Methods: A new “chronic paronychia severity index scale” was developed to enable dermatologists to examine all features of CP. A previous categorical severity scale and this new scale were used for the evaluation of CP by 6 different dermatologists. The dermatologists evaluated the nails with both scales again 20 days later using randomly ordered photographs. Results: Using the previous scale, the intra-observer intraclass correlation coefficient (ICC) values between the first and second evaluations were 0.767, 0.860, 0.734, 0.609, 0.900, and 0.840 for the 6 dermatologists. Using the new proposed scale, the intra-observer ICC values between the first and second evaluations were 0.930, 0.931, 0.942, 0.934, 0.938, and 0.920 for the 6 dermatologists. All intra-observer ICC values were higher for the results of the proposed scale than for those of the previous scale. The inter-observer ICC values were also higher for the proposed scale than for the previous scale for the 6 dermatologists. Conclusion: The new scale is a standardized, more suitable, objective, and valuable method to use in clinical practice and studies on CP.


  • Unilateral improvement of nail psoriasis with denervation injury

    by A. S. Keçici, F. Göktay, K. Tutkavul, P. Güneş, Ş. Yaşar


  • Open Access

    Syphilis

    by Ayşegül Sevim Keçici

    Syphilis is a sexually transmitted disease caused by the spirochete . It is transmissible by sexual contact, from mother to fetus, via blood transfusion, and occasionally by direct contact with infectious lesions. It has been a major public health problem both before the antibiotic era and now, with the increase of acquired immunodeficiency states and unprotected sex. The clinical manifestations of the disease can mimic many other infections and immune-mediated diseases; thus, it may be difficult to make early diagnosis. After the discovery of penicillin in the twentieth century, the spread of the disease has been largely controlled, but up to now, it has not been fully eradicated. In this chapter, overall information about the disease including the epidemiology, clinical presentation forms, pathophysiological mechanisms, and latest diagnostic and treatment approaches are reviewed.


  • Bacterial infections of the folds (intertriginous areas)

    by Yalçın Tüzün, Ronni Wolf, Burhan Engin, Ayşegül Sevim Keçici, Zekayi Kutlubay


  • Behçet’s disease as a systemic disease

    by M. Cem Mat, Ayşegül Sevim, İzzet Fresko, Yalçın Tüzün